Enochian Biosciences, Inc.
ENOB · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $1,874,480 | $9 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $2 | $690,925 | $0 |
| Total Curr. Assets | $1 | $2 | $2,565,405 | $10 |
| Property Plant & Equip (Net) | $1 | $2 | $1,422,974 | $2 |
| Goodwill | $6 | $159 | $11,640,000 | $12 |
| Intangibles | $0 | $0 | $39,676 | $62 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $42,632,741 | $0 |
| Total NC Assets | $7 | $161 | $55,735,391 | $75 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $8 | $163 | $58,300,796 | $85 |
| Liabilities | – | – | – | – |
| Payables | $13 | $9 | $5,296,823 | $1 |
| Short-Term Debt | $10 | $3 | $4,818,369 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $18 | $907,906 | $4 |
| Total Curr. Liab. | $29 | $30 | $11,023,098 | $6 |
| LT Debt | $0 | $1 | $775,587 | $6 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $1 | $775,587 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $969,009 | $1 |
| Total Liabilities | $30 | $31 | $11,798,685 | $12 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $6,371 | $0 |
| Retained Earnings | -$510 | -$325 | -$244,029,253 | -$204 |
| AOCI | $11 | -$0 | -$29,882 | -$0 |
| Other Equity | $478 | $457 | $290,554,875 | $277 |
| Total Equity | -$21 | $132 | $46,502,111 | $73 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $8 | $163 | $58,300,796 | $85 |
| Net Debt | $10 | $4 | $3,719,476 | -$2 |